Locally Advanced or Metastatic Pancreatic Cancer
5 clinical trials · Condition
◉ Watch Locally Advanced or Metastatic Pancreatic Cancer
| Record | Firm | Date |
|---|---|---|
| Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient with Pancreatic Cancer (NCT03579836) | BeyondBio Inc. | 2018-05-14 |
| SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer (NCT03443492) | National Health Research Institutes, Taiwan | 2018-03-26 |
| Masitinib Plus Gemcitabine in Pancreatic Cancer (NCT03766295) | AB Science | 2014-07-01 |
| A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreatic Cancer (NCT01181245) | Kyntra Bio | 2008-12-01 |
| Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer (NCT00651742) | Taiho Oncology, Inc. | 2006-01-09 |
Track Locally Advanced or Metastatic Pancreatic Cancer automatically
Every clearance here is in the API, with alerts when new ones post.